Opinion/decision on a Paediatric investigation plan (PIP): Spravato, esketamine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: EMA/PE/0000224110

Submitted by Anonymous (not verified) on 11 March 2026 - 14:00

Opinion/decision on a Paediatric investigation plan (PIP): Spravato, esketamine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: EMA/PE/0000224110

Human medicines European public assessment report (EPAR): Winrevair, sotatercept, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 11 March 2026 - 14:00

Human medicines European public assessment report (EPAR): Winrevair, sotatercept, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness